| 3-DG | 3-deoxyglucosone |
| 4-HNE | 4-hydroxynonenal |
| AGEs | Advanced glycation end products |
| AP-1 | Activator protein 1 |
| ARE | Antioxidant response element |
| BC | Breast cancer |
| BCRP | Breast cancer resistance protein |
| BSA | Bovine serum albumin |
| CAND1 | Cullin-associated NEDD8-dissociated protein 1 |
| ChREBP | Carbohydrate response element binding protein |
| CUL3 | Cullin3 |
| eIF1 | Eukaryotic translation initiation factor 1 |
| eIF3G | Eukaryotic translation initiation factor 3 subunit G |
| elF4A1 | Eukaryotic initiation factor 4A-I |
| eNOS | Endothelial nitric oxide synthase |
| EMT | Epithelial–mesenchymal transition |
| FGFR | Human fibroblast growth factor receptor |
| FL6PDG | Fructoselysine-6-phosphate deglycase |
| FN3K | Fructosamine-3-kinase |
| FN3K-RP | Fructosamine-3-kinase-related-protein |
| FN6K | Fructosamine-6-kinase |
| GCLC | Glutamate-cysteine ligase catalytic subunit |
| GCLM | Glutamate cysteine ligase modifier subunit |
| GPx | Glutathione peroxidase |
| GSH | Glutathione |
| GST | Glutathione S-transferase |
| HbA1c | Glycated hemoglobin |
| HBXIP | Mammalian hepatitis B X-interacting protein |
| HCC | Hepatocellular carcinoma |
| HELB | DNA helicase B |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HMGB1 | High mobility group box-1 |
| HO1 | Heme oxygenase-1 |
| HSP | Heat shock protein |
| HSP90AA1 | Heat shock protein 90 alpha family class A member 1 |
| HSP90AA4 | Heat shock protein 90 alpha family class A member 4 |
| ICAM-1 | Intercellular Adhesion Molecule 1 |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin 6 |
| JAK | Janus kinase |
| Keap1 | Kelch-like ECH-associated protein 1 |
| KRAS | Kirsten rat sarcoma viral oncogene homologue |
| LDHA | Lactate dehydrogenase A |
| LDHC | Lactate dehydrogenase C |
| MAF | Musculoaponeurotic fibrosarcoma |
| Maf | Musculoaponeurotic fibrosarcoma |
| MAPK | Mitogen activated protein kinase |
| MCM3 | Minichromosome maintenance complex component 3 |
| MD | Malondialdehyde |
| MGO | Methylglyoxal |
| MMPs | Matrix metalloproteinases/Matrix metallopeptidases |
| mTOR | Mammalian target of rapamycin |
| NAD(P)H | Reduced nicotinamide adenine dinucleotide phosphate |
| NFE2L2 | Nuclear factor erythroid-derived 2-like 2 gene |
| NF-κB | Nuclear factor kappa—B |
| NOX | NADPH oxidases |
| NQO1 | NAD(P)H:quinone oxidoreductase 1 |
| Nrf2 | Nuclear factor erythroid 2 (NFE2)-related factor 2 |
| NSCLC | Non small cell lung carcinoma |
| NSMIs | Novel small molecule inhibitors |
| p53 | Tumor protein p53/phosphoprotein p53/tumor suppressor p53 |
| pERK | Protein kinase R-like endoplasmic reticulum kinase |
| PI3K | Phosphoinositide 3-kinase |
| PNG-1 | Peptide N-Glycanase 1 |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PUF60 | Poly(U)-binding-splicing factor |
| RAGEs | Receptors for advanced glycation end products |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| SCLCs | Squamous cell lung carcinomas |
| sMaf | small Maf proteins |
| SOD | Superoxide dismutase |
| SRSF7 | Serine/arginine-rich splicing factor 7 |
| STAT3 | Signal transducer and activator of transcription 3 |
| TAMs | Tumor-associated macrophages |
| TCGA | The cancer genome atlas |
| TNF | Tumor necrosis factor |
| TNFR-1 | Tumor necrosis factor receptor 1 |
| TNF-α | Tumor necrosis factor alpha |
| Txn | Thioredoxin |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| VEGF | Vascular endothelial growth factor |
| YES1 | YES proto-oncogene 1 |